Paul Guedeney

3.7k total citations
90 papers, 1.6k citations indexed

About

Paul Guedeney is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul Guedeney has authored 90 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Cardiology and Cardiovascular Medicine, 42 papers in Surgery and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul Guedeney's work include Acute Myocardial Infarction Research (34 papers), Atrial Fibrillation Management and Outcomes (23 papers) and Coronary Interventions and Diagnostics (20 papers). Paul Guedeney is often cited by papers focused on Acute Myocardial Infarction Research (34 papers), Atrial Fibrillation Management and Outcomes (23 papers) and Coronary Interventions and Diagnostics (20 papers). Paul Guedeney collaborates with scholars based in France, United States and Italy. Paul Guedeney's co-authors include Gilles Montalescot, Bimmer E. Claessen, Jean‐Philippe Collet, Sabato Sorrentino, Johanne Silvain, Mathieu Kernéis, Michel Zeitouni, Roxana Mehran, George Dangas and Birgit Vogel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Paul Guedeney

82 papers receiving 1.6k citations

Peers

Countries citing papers authored by Paul Guedeney

Since Specialization

Citations

This map shows the geographic impact of Paul Guedeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Guedeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Guedeney more than expected).

Fields of papers citing papers by Paul Guedeney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Guedeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Guedeney. The network helps show where Paul Guedeney may publish in the future.

Co-authorship network of co-authors of Paul Guedeney

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Guedeney. A scholar is included among the top collaborators of Paul Guedeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Guedeney. Paul Guedeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Feasibility and early outcomes of atrial septal defect prostheses use for percutaneous closure of widely open patent foramen ovale 2024 ·European Heart Journal ·(unknown), Paul Guedeney, Johanne Silvain, Michel Zeitouni, (unknown), (unknown), (unknown), Niki Procopi, Nadjib Hammoudi, G Montalescot	1
2	Early Nonprocedural Bleeding After Left Atrial Appendage Occlusion 2024 ·JACC: Cardiovascular Interventions ·Jules Mesnier, Ignacio Cruz‐González, Paul Guedeney, Dabit Arzamendi, Xavier Freixa, Luis Nombela‐Franco, Vicente Peral, Berenice Caneiro‐Queija, Antonio Mangieri, (unknown), Lluís Asmarats, Pedro Cepas‐Guillén, Pablo Salinas, (unknown), Rodrigo Estévez‐Loureiro, Alessandra Laricchia, Gilles O’Hara, Gilles Montalescot, Josep Rodés‐Cabau	2
3	Ten-year trends in characteristics, management and outcomes of patients admitted with cardiogenic shock in the ACTION-SHOCK cohort 2024 ·Archives of cardiovascular diseases ·(unknown), (unknown), (unknown), Niki Procopi, Mathieu Kernéis, Paul Guedeney, Olivier Barthélémy, (unknown), Stéphanie Rouanet, Delphine Brugier, (unknown), Juliette Chommeloux, (unknown), (unknown), Jean‐Philippe Collet, Gilles Montalescot, Michel Zeitouni	3
4	Impact of the antiplatelet strategy following patent foramen ovale percutaneous closure 2023 ·European Heart Journal ·Paul Guedeney, Julio I. Farjat‐Pasos, (unknown), Vincent Roule, Alexis Hermida, Fang Huang, Benoît Lattuca, Florence Leclercq, Jules Mesnier, Jérémie Abtan, Stéphanie Rouanet, Michel Zeitouni, Johanne Silvain, Gilles Montalescot, J Rodés-Cabau	1
5	Patent Foramen Ovale Percutaneous Closure: Evolution and Ongoing Challenges 2023 ·Journal of Clinical Medicine ·(unknown), Paul Guedeney, Gilles Montalescot	4
6	P2Y12 inhibitor loading time before elective PCI and the prevention of myocardial necrosis 2023 ·Archives of cardiovascular diseases ·Vincent Roule, Farzin Beygui, Guillaume Cayla, Grégoire Rangé, Zuzana Moťovská, Nicolas Delarche, François Jourda, (unknown), Paul Guedeney, Michel Zeitouni, (unknown), Mikaël Laredo, Éric Vicaut, Gilles Montalescot, Johanne Silvain	0
7	Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials 2023 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Paul Guedeney, Vincent Roule, Jules Mesnier, Céline Chapelle, Jean-Jacques Portal, Silvy Laporte, Édouard Ollier, Michel Zeitouni, Mathieu Kernéis, Niki Procopi, Olivier Barthélémy, Sabato Sorrentino, (unknown), Johanne Silvain, Éric Vicaut, Gilles Montalescot, Jean‐Philippe Collet	8
8	Comparison of three echo-guidance techniques in percutaneous patent foramen ovale closure for stroke prevention: Conventional transoesophageal, microprobe transoesophageal and intracardiac echocardiography 2023 ·Archives of cardiovascular diseases ·(unknown), Marie Hauguel‐Moreau, Paul Guedeney, (unknown), Nadjib Hammoudi, Guillaume Duthoit, Michel Zeitouni, Benoît Lattuca, Mathieu Kernéis, Jean‐Philippe Collet, Johanne Silvain, Gilles Montalescot	0
9	Bioprosthetic leaflet thrombosis and reduced leaflet motion after transcatheter aortic valve replacement: A systematic review and meta-analysis 2023 ·Archives of cardiovascular diseases ·Vincent Roule, Paul Guedeney, Johanne Silvain, Farzin Beygui, Michel Zeitouni, Sabato Sorrentino, Mathieu Kernéis, Olivier Barthélémy, (unknown), Jean-Jacques Portal, Éric Vicaut, Gilles Montalescot, Jean‐Philippe Collet	3
10	Impact of transit-time flow measurement on early postoperative outcomes in total arterial coronary revascularization with internal thoracic arteries: a propensity score analysis on 910 patients 2022 ·Interactive Cardiovascular and Thoracic Surgery ·(unknown), (unknown), Pierre Demondion, Cosimo D’Alessandro, Paul Guedeney, (unknown), Guillaume Lebreton, Pascal Leprince	3
11	Supraventricular Arrhythmia Following Patent Foramen Ovale Percutaneous Closure 2022 ·JACC: Cardiovascular Interventions ·Paul Guedeney, Mikaël Laredo, Michel Zeitouni, Marie Hauguel‐Moreau, (unknown), (unknown), Sonia Alamowitch, Sophie Crozier, Candice Sabben, S. Deltour, Michaël Obadia, (unknown), Jean‐Philippe Collet, (unknown), Nadjib Hammoudi, Johanne Silvain, Gilles Montalescot	26
12	Outcomes of Vascular Closure Device Use After Transfemoral Coronary Intervention: Insights From the EXCEL Trial 2021 ·The Journal of invasive cardiology ·Toshiki Kuno, Bimmer E. Claessen, Paul Guedeney, Patrick W. Serruys, Joseph F. Sabik, Charles A. Simonton, David E. Kandzari, Marie‐Claude Morice, Zixuan Zhang, Ovidiu Dressler, Roxana Mehran, Ori Ben‐Yehuda, A. Pieter Kappetein, Gregg W. Stone	2
13	Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 2020 ·Journal of Clinical Medicine ·Paul Guedeney, Jules Mesnier, Sabato Sorrentino, (unknown), Michel Zeitouni, Benoît Lattuca, Johanne Silvain, Salvatore De Rosa, Ciro Indolfi, Jean‐Philippe Collet, Mathieu Kernéis, Gilles Montalescot	10
14	Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review 2020 ·Journal of the American Heart Association ·Bimmer E. Claessen, Paul Guedeney, C. Michael Gibson, Dominick J. Angiolillo, Davide Cao, Norman E. Lepor, Roxana Mehran	33
15	Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis 2020 ·European Heart Journal - Cardiovascular Pharmacotherapy ·Paul Guedeney, Sabato Sorrentino, Gennaro Giustino, Céline Chapelle, Silvy Laporte, Bimmer E. Claessen, Édouard Ollier, Anton Camaj, Deborah N. Kalkman, Birgit Vogel, Salvatore De Rosa, Ciro Indolfi, Benoît Lattuca, Michel Zeitouni, Mathieu Kernéis, Johanne Silvain, Jean‐Philippe Collet, Roxana Mehran, Gilles Montalescot	44
16	Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention 2019 ·The American Journal of Cardiology ·Paul Guedeney, Bimmer E. Claessen, Usman Baber, Anton Camaj, Sabato Sorrentino, Melissa Aquino, (unknown), Rishi Chandiramani, Ridhima Goel, (unknown), Jason C. Kovacic, Joseph Sweeny, Nitin Barman, Pedro Moreno, George Dangas, Annapoorna Kini, Sanjeev Sharma, Roxana Mehran	7
17	Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials 2019 ·European Heart Journal ·Paul Guedeney, Gennaro Giustino, Sabato Sorrentino, Bimmer E. Claessen, Anton Camaj, Deborah N. Kalkman, Birgit Vogel, Samantha Sartori, Salvatore De Rosa, Usman Baber, Ciro Indolfi, Gilles Montalescot, George Dangas, Robert S. Rosenson, Stuart Pocock, Roxana Mehran	147
18	Small‐vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus‐eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post‐Approval studies 2019 ·Catheterization and Cardiovascular Interventions ·Paul Guedeney, Bimmer E. Claessen, Roxana Mehran, David E. Kandzari, Melissa Aquino, Scott Davis, (unknown), John Wang, (unknown), Osvaldo Gigliotti, (unknown), Sarabjeet Singh, (unknown), Gregory Giugliano, Phillip A. Horwitz, Sabato Sorrentino, Paul Underwood, Dominic J. Allocco, Ian T. Meredith, Wayne Batchelor	8
19	Do Patients need Lifelong β-Blockers after an Uncomplicated Myocardial Infarction? 2019 ·American Journal of Cardiovascular Drugs ·Michel Zeitouni, Mathieu Kernéis, Benoît Lattuca, Paul Guedeney, Guillaume Cayla, Jean‐Philippe Collet, Gilles Montalescot, Johanne Silvain	17
20	Quel traitement antithrombotique après un remplacement valvulaire aortique percutané ? 2019 ·Annales de Cardiologie et d Angéiologie ·Paul Guedeney, Jean‐Philippe Collet	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact